Asthma Clinical Trial
Official title:
Asthma Control Among Patients Who Were Receiving Inhaled Corticosteroids in General Practice in Thailand
| Verified date | December 2010 |
| Source | AstraZeneca |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Thailand: Ethical Committee |
| Study type | Observational |
The purpose of this study is to determine the percentage of patients who has reached the GINA guideline of asthma treatment after receiving any inhaled corticosteroid for 3 months or longer in actual clinical practice. Such percentage for each level of severity - mild, moderate and severe persistent asthma as well as the differences of these rates will also be explored.
| Status | Completed |
| Enrollment | 1210 |
| Est. completion date | November 2009 |
| Est. primary completion date | |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 12 Years and older |
| Eligibility |
Inclusion Criteria: - Established persistent asthma - Currently treated with any inhaled corticosteroid therapy but not SYMBICORT nor SERETIDE for 3 months or longer Exclusion Criteria: - Currently participating or have participated in a study with an investigational compound within the last 30 days - Current diagnosis of chronic obstructive pulmonary disease (COPD) - Smoked more than 10 packs a year |
Time Perspective: Retrospective
| Country | Name | City | State |
|---|---|---|---|
| Thailand | Research Site | Amnat Charoen | |
| Thailand | Research Site | Buriram | |
| Thailand | Research Site | Chachoengsao | |
| Thailand | Research Site | Chaiyaphum | |
| Thailand | Research Site | Chanthaburi | |
| Thailand | Research Site | Chiang Rai | |
| Thailand | Research Site | Kalasin | |
| Thailand | Research Site | Khon Kaen | |
| Thailand | Research Site | Lopburi | |
| Thailand | Research Site | Mae Hong Son | |
| Thailand | Research Site | Mahasarakham | |
| Thailand | Research Site | Nakhon Phanom | |
| Thailand | Research Site | Nakhorn Ratchasima | |
| Thailand | Research Site | Nan | |
| Thailand | Research Site | Nong Khai | |
| Thailand | Research Site | Samutsongkhram | |
| Thailand | Research Site | Si Sa Ket | |
| Thailand | Research Site | Singburi | |
| Thailand | Research Site | Songkla | |
| Thailand | Research Site | Sukhothai | |
| Thailand | Research Site | Surat Thani | |
| Thailand | Research Site | Trang | |
| Thailand | Research Site | Trat | |
| Thailand | Research Site | Ubon Ratchathani | |
| Thailand | Research Site | Udon Thani | |
| Thailand | Research Site | Yasothon |
| Lead Sponsor | Collaborator |
|---|---|
| AstraZeneca |
Thailand,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Asthma control test | On the survey date | No | |
| Secondary | Asthma control in mild, moderate and severe persistent asthma patients | On the survey date | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|